Inventors:
Stephen Todd - San Francisco CA, US
Angelo M. Delegeane - Milpitas CA, US
Ameena R. Gandhi - San Francisco CA, US
Danniel B. Nguyen - San Jose CA, US
April J. A. Hafalia - Daly City CA, US
Liam Kearney - San Francisco CA, US
Yan Lu - Palo Alto CA, US
Ernestine A. Lee - Castro Valley CA, US
Narinder K. Chawla - Union City CA, US
Debopriya Das - Mountain View CA, US
Chandra S. Arvizu - San Jose CA, US
Monique G. Yao - Carmel IN, US
Deborah A. Kallick - Stanford CA, US
Vicki S. Elliott - San Jose CA, US
Li Ding - Creve Coeur MO, US
Henry Yue - Sunnyvale CA, US
Roopa M. Reddy - Fremont CA, US
Dyung Aina M. Lu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Junming Yang - San Jose CA, US
Catherine M. Tribouley - San Francisco CA, US
Neil Burford - Durham CT, US
Mariah R. Baughn - San Leandro CA, US
Preeti G. Lal - Santa Clara CA, US
Mark L. Borowsky - Redwood City CA, US
Farrah A. Khan - Des Plaines IL, US
Rajagopal Gururajan - San Jose CA, US
Y. Tom Tang - San Jose CA, US
Janice K. Au-Young - Brisbane CA, US
Bridget A. Warren - Encinitas CA, US
Roberto Hernandez - Canterbury, GB
Brendan M. Duggan - Sunnyvale CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C12N009/64
C12N001/20
C12N015/00
C12N015/63
C07H021/04
US Classification:
435226, 4352523, 43525233, 435325, 4353201, 435348, 435419, 4352541, 4352542, 536 232
Abstract:
The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.
